232 related articles for article (PubMed ID: 19409593)
1. Enhanced papillomavirus-like particle production in insect cells.
Senger T; Schädlich L; Gissmann L; Müller M
Virology; 2009 Jun; 388(2):344-53. PubMed ID: 19409593
[TBL] [Abstract][Full Text] [Related]
2. Production of human papillomavirus type 33 L1 major capsid protein and virus-like particles from Bacillus subtilis to develop a prophylactic vaccine against cervical cancer.
Baek JO; Seo JW; Kwon O; Park SM; Kim CH; Kim IH
Enzyme Microb Technol; 2012 Mar; 50(3):173-80. PubMed ID: 22305172
[TBL] [Abstract][Full Text] [Related]
3. Expression of human papillomavirus type 6 L1 and L2 isolated in China and self assembly of virus-like particles by the products.
Wang M; Wang LL; Chen LF; Han YH; Zou YH; Si JY; Song GX
Sheng Wu Hua Xue Yu Sheng Wu Wu Li Xue Bao (Shanghai); 2003 Jan; 35(1):27-34. PubMed ID: 12518224
[TBL] [Abstract][Full Text] [Related]
4. The L1 major capsid protein of human papillomavirus type 16 variants affects yield of virus-like particles produced in an insect cell expression system.
Touze A; El Mehdaoui S; Sizaret PY; Mougin C; Muñoz N; Coursaget P
J Clin Microbiol; 1998 Jul; 36(7):2046-51. PubMed ID: 9650960
[TBL] [Abstract][Full Text] [Related]
5. Production and Application of Insect Virus-Based VLPs.
Gopal R; Schneemann A
Methods Mol Biol; 2018; 1776():125-141. PubMed ID: 29869238
[TBL] [Abstract][Full Text] [Related]
6. Broad Cross-Protection Is Induced in Preclinical Models by a Human Papillomavirus Vaccine Composed of L1/L2 Chimeric Virus-Like Particles.
Boxus M; Fochesato M; Miseur A; Mertens E; Dendouga N; Brendle S; Balogh KK; Christensen ND; Giannini SL
J Virol; 2016 Jul; 90(14):6314-25. PubMed ID: 27147749
[TBL] [Abstract][Full Text] [Related]
7. Combined truncations at both N- and C-terminus of human papillomavirus type 58 L1 enhanced the yield of virus-like particles produced in a baculovirus system.
Wang Z; Zhang T; Xu X
J Virol Methods; 2022 Mar; 301():114403. PubMed ID: 34890711
[TBL] [Abstract][Full Text] [Related]
8. Expression of human papillomavirus type 11 L1 protein in insect cells: in vivo and in vitro assembly of viruslike particles.
Rose RC; Bonnez W; Reichman RC; Garcea RL
J Virol; 1993 Apr; 67(4):1936-44. PubMed ID: 8383219
[TBL] [Abstract][Full Text] [Related]
9. Generation and neutralization of pseudovirions of human papillomavirus type 33.
Unckell F; Streeck RE; Sapp M
J Virol; 1997 Apr; 71(4):2934-9. PubMed ID: 9060652
[TBL] [Abstract][Full Text] [Related]
10. Chimeric L2-Based Virus-Like Particle (VLP) Vaccines Targeting Cutaneous Human Papillomaviruses (HPV).
Huber B; Schellenbacher C; Shafti-Keramat S; Jindra C; Christensen N; Kirnbauer R
PLoS One; 2017; 12(1):e0169533. PubMed ID: 28056100
[TBL] [Abstract][Full Text] [Related]
11. Development a scalable production process for truncated human papillomavirus type-6 L1 protein using WAVE Bioreactor and hollow fiber membrane.
Sun B; Zhao D; Zhang X; Gu T; Yu X; Sun S; Zhao X; Wei L; Liu D; Yan H; Meng X; Kong W; Xu F; Yang P; Jiang C
Appl Microbiol Biotechnol; 2016 Feb; 100(3):1231-1240. PubMed ID: 26446387
[TBL] [Abstract][Full Text] [Related]
12. Targeted supplementation design for improved production and quality of enveloped viral particles in insect cell-baculovirus expression system.
Monteiro F; Bernal V; Chaillet M; Berger I; Alves PM
J Biotechnol; 2016 Sep; 233():34-41. PubMed ID: 27378622
[TBL] [Abstract][Full Text] [Related]
13. Expression and self-assembly in baculovirus of porcine enteric calicivirus capsids into virus-like particles and their use in an enzyme-linked immunosorbent assay for antibody detection in swine.
Guo M; Qian Y; Chang KO; Saif LJ
J Clin Microbiol; 2001 Apr; 39(4):1487-93. PubMed ID: 11283075
[TBL] [Abstract][Full Text] [Related]
14. Enhanced mucosal and systemic immune responses following intravaginal immunization with human papillomavirus 16 L1 virus-like particle vaccine in thermosensitive mucoadhesive delivery systems.
Park JS; Oh YK; Kang MJ; Kim CK
J Med Virol; 2003 Aug; 70(4):633-41. PubMed ID: 12794729
[TBL] [Abstract][Full Text] [Related]
15. VLP production in Leishmania tarentolae: A novel expression system for purification and assembly of HPV16 L1.
Bolhassani A; Shirbaghaee Z; Agi E; Davoudi N
Protein Expr Purif; 2015 Dec; 116():7-11. PubMed ID: 26304732
[TBL] [Abstract][Full Text] [Related]
16. Self-Assembling Plant-Derived Vaccines Against Papillomaviruses.
Noris E
Methods Mol Biol; 2018; 1776():85-95. PubMed ID: 29869236
[TBL] [Abstract][Full Text] [Related]
17. [Production of HPV 16 major capsid protein L1 with baculovirus expression system].
Zheng B; Wang J; Jiang H
Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2001 Dec; 15(4):314-6. PubMed ID: 11986713
[TBL] [Abstract][Full Text] [Related]
18. Hybrid papillomavirus L1 molecules assemble into virus-like particles that reconstitute conformational epitopes and induce neutralizing antibodies to distinct HPV types.
Christensen ND; Cladel NM; Reed CA; Budgeon LR; Embers ME; Skulsky DM; McClements WL; Ludmerer SW; Jansen KU
Virology; 2001 Dec; 291(2):324-34. PubMed ID: 11878901
[TBL] [Abstract][Full Text] [Related]
19. Production and purification of human papillomavirus type 33 L1 virus-like particles from Spodoptera frugiperda 9 cells using two-step column chromatography.
Baek JO; Seo JW; Kim IH; Kim CH
Protein Expr Purif; 2011 Feb; 75(2):211-7. PubMed ID: 20716445
[TBL] [Abstract][Full Text] [Related]
20. Papillomavirus-like particles for serology and vaccine development.
Kirnbauer R
Intervirology; 1996; 39(1-2):54-61. PubMed ID: 8957670
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]